Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
View Top Employees from Excision BioTherapeutics| Website | https://www.excision.bio |
| Revenue | $2 million |
| Employees | 46 (36 on RocketReach) |
| Founded | 2015 |
| Address | 988 Market St, San Francisco, California 94102, US |
| Industry | Biotechnology, Business Services General, Drug Discovery, Gene Editing Therapeutics, Business Services, Science and Engineering, Neurotropic Viruses, Health Care, Therapeutics |
| Web Rank | 12 Million |
| Keywords | Excisionbio, Excision Biotherapeutics, Multiplex Biologic, Excision Bio |
| Competitors | Alios BioPharma, American Gene Technologies® International Inc., Hummingbird Bioscience, NeurOp, Inc., Neuren Pharmaceuticals |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular Excision BioTherapeutics employee's phone or email?
Excision BioTherapeutics Questions
The Excision BioTherapeutics annual revenue was $2 million in 2024.
Rose Ann Branca is the Vice President Clinical Operations of Excision BioTherapeutics.
36 people are employed at Excision BioTherapeutics.
Excision BioTherapeutics is based in San Francisco, California.
The NAICS codes for Excision BioTherapeutics are [54, 5417, 54171, 541714, 541].
The SIC codes for Excision BioTherapeutics are [87, 873].
Top Excision BioTherapeutics Employees
-
5+5+
-
ViewManish A
Senior Vice President, Regulatory Affairs at Excision BioTherapeutics
San Francisco, CA, US -
ViewChristine Silverstein
Chief Financial Officer at Excision BioTherapeutics
New York, New York, United States32 -
45+
-
View
Meltem Isik
Associate Director at Excision BioTherapeutics
Cambridge, Massachusetts, United States21 -
2
Related Companies
